Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2011 1
2013 1
2014 3
2015 8
2016 4
2017 4
2018 2
2019 2
2020 6
2021 8
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Updates on systemic therapy for cervical cancer.
Gopu P, Antony F, Cyriac S, Karakasis K, Oza AM. Gopu P, et al. Among authors: karakasis k. Indian J Med Res. 2021 Aug;154(2):293-302. doi: 10.4103/ijmr.IJMR_4454_20. Indian J Med Res. 2021. PMID: 35295013 Free PMC article. Review.
Optimizing clinical research procedures in public health emergencies.
Madariaga A, Kasherman L, Karakasis K, Degendorfer P, Heesters AM, Xu W, Husain S, Oza AM. Madariaga A, et al. Among authors: karakasis k. Med Res Rev. 2021 Mar;41(2):725-738. doi: 10.1002/med.21749. Epub 2020 Nov 11. Med Res Rev. 2021. PMID: 33174617 Review.
Ovarian cancer treatment: The end of empiricism?
Lheureux S, Karakasis K, Kohn EC, Oza AM. Lheureux S, et al. Among authors: karakasis k. Cancer. 2015 Sep 15;121(18):3203-11. doi: 10.1002/cncr.29481. Epub 2015 Jun 10. Cancer. 2015. PMID: 26096019 Free PMC article. Review.
Safety evaluation of olaparib for treating ovarian cancer.
Lheureux S, Bowering V, Karakasis K, Oza AM. Lheureux S, et al. Among authors: karakasis k. Expert Opin Drug Saf. 2015 Aug;14(8):1305-16. doi: 10.1517/14740338.2015.1045875. Epub 2015 Jun 8. Expert Opin Drug Saf. 2015. PMID: 26051946 Review.
Outcomes and endpoints in cancer trials: bridging the divide.
Wilson MK, Collyar D, Chingos DT, Friedlander M, Ho TW, Karakasis K, Kaye S, Parmar MK, Sydes MR, Tannock IF, Oza AM. Wilson MK, et al. Among authors: karakasis k. Lancet Oncol. 2015 Jan;16(1):e43-52. doi: 10.1016/S1470-2045(14)70380-8. Epub 2014 Dec 29. Lancet Oncol. 2015. PMID: 25638556 Review.
39 results